DA
IRMD icon

Denali Advisors’s iRadimed IRMD Stock Holding History

Denali Advisors’s Portfolio IRMD Stock Details IRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-5,700
Closed -$251K – 322
2024
Q1 		$251K Sell
5,700
-2,000
-26% -$88.4K 0.07% 206
2023
Q4 		$366K Buy
7,700
+1,800
+31% +$75.7K 0.11% 181
2023
Q3 		$262K Hold
5,900
– – 0.09% 198
2023
Q2 		$282K Buy
+5,900
New +$266K 0.1% 192
2021
Q2 		– Sell
-800
Closed -$21K – 321
2021
Q1 		$21K Hold
800
– – 0.01% 280
2020
Q4 		$18K Hold
800
– – ﹤0.01% 316
2020
Q3 		$17K Hold
800
– – ﹤0.01% 333
2020
Q2 		$19K Hold
800
– – ﹤0.01% 349
2020
Q1 		$17K Buy
+800
New +$19.1K ﹤0.01% 317

Other funds holding IRMD

NTCM
Nine Ten Capital Management Chicago, Illinois $315M AUM 62.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.5B AUM 18.67% 1-Year Est. Return
BCM
Bares Capital Management Austin, Texas $1.08B AUM 38.13% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
RCMC
RK Capital Management (Colorado) Denver, Colorado $324K AUM 47.52% 1-Year Est. Return

Denali Advisors's IRMD Position: Q2 2024 in Review

Denali Advisors sold out of iRadimed (IRMD) in Q2 2024, closing a stake of 5,700 shares — an estimated $251K sold.

Denali Advisors first reported a position in IRMD in Q1 2020 and held it in 9 quarters. The position peaked at $366K in Q4 2023. 138 funds tracked by Wall St. Rank hold IRMD as of Q2 2024.

  • Denali Advisors reported no remaining iRadimed position as of Q2 2024 after selling out during the quarter.
  • Denali Advisors sold 5,700 iRadimed shares in Q2 2024, an estimated $251K.
  • Denali Advisors first reported a position in iRadimed in Q1 2020 and held it in 9 quarters.
  • Denali Advisors's iRadimed position peaked at $366K in Q4 2023.
  • 138 funds tracked by Wall St. Rank held iRadimed as of Q2 2024.

Based on Denali Advisors's 13F filing for Q2 2024, filed 9 Aug 2024.